Image of Gail H Cassell

Gail H Cassell, Ph.D.

Dr. Cassell is vice president for TB Drug Development at the Infectious Disease Research Institute in Seattle, Washington, professor emeritus and former chair, Department of Microbiology, University of Alabama at Birmingham, and former vice president for scientific affairs and distinguished Lilly research scholar for infectious diseases at Eli Lilly and Company in Indianapolis, Indiana. She founded the Forum on Drug Discovery, Development and Translation, which she continues to co-chair, at the Institute of Medicine. She has a distinguished record of national service with the National Academy of Sciences, National Institutes of Health, Centers for Disease Control, and several other national and international institutions.

Affiliations:

Division of Global Health Equity, Brigham and Women's Hospital

Dr. Cassell is a leader on efforts to address multidrug-resistant tuberculosis (MDRTB). She and Barry Bloom, former dean of Harvard School of Public Health, co-lead an Institute of Medicine project on drug supply chain issues related to MDRTB. She actively advises numerous government agencies, NGOs, and foundations on the scale-up of MDRTB diagnosis and treatment in endemic areas around the world, including in Russia. Dr. Cassell is advising the GHSM Sentinel Project on pediatric drug-resistant tuberculosis, a global partnership that aims to develop and deploy evidence-based strategies to prevent child deaths from drug-resistant tuberculosis.

The role of scientific societies in addressing the threats of emerging infections: summary of roundtable discussion.
Authors: Authors: Cassell GH, Shimao T.
FEMS Immunol Med Microbiol
View full abstract on Pubmed
Evaluation of the Etest for detection of tetracycline resistance in Mycoplasma hominis.
Authors: Authors: Waites KB, Crabb DM, Duffy LB, Cassell GH.
Diagn Microbiol Infect Dis
View full abstract on Pubmed
Isolation of Mycoplasma hominis from a brain abscess.
Authors: Authors: Zheng X, Olson DA, Tully JG, Watson HL, Cassell GH, Gustafson DR, Svien KA, Smith TF.
J Clin Microbiol
View full abstract on Pubmed
Resistance to mycoplasmal lung disease in mice is a complex genetic trait.
Authors: Authors: Cartner SC, Simecka JW, Briles DE, Cassell GH, Lindsey JR.
Infect Immun
View full abstract on Pubmed
Epitope mapping of the variable repetitive region with the MB antigen of Ureaplasma urealyticum.
Authors: Authors: Zheng X, Lau K, Frazier M, Cassell GH, Watson HL.
Clin Diagn Lab Immunol
View full abstract on Pubmed
Phylogenetic analysis of genes coding for 16S rRNA in mammalian ureaplasmas.
Authors: Authors: Harasawa R, Cassell GH.
Int J Syst Bacteriol
View full abstract on Pubmed
Phylogenetic analysis of the 16S-23S rRNA intergenic spacer regions of the genus Ureaplasma.
Authors: Authors: Harasawa R, Lefkowitz EJ, Glass JI, Cassell GH.
J Vet Med Sci
View full abstract on Pubmed
Sequence analysis of the chromosomal region around and within the V-1-encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation.
Authors: Authors: Simmons WL, Zuhua C, Glass JI, Simecka JW, Cassell GH, Watson HL.
Infect Immun
View full abstract on Pubmed
Comparative severity of respiratory lesions of sialodacryoadenitis virus and Sendai virus infections in LEW and F344 rats.
Authors: Authors: Liang SC, Schoeb TR, Davis JK, Simecka JW, Cassell GH, Lindsey JR.
Vet Pathol
View full abstract on Pubmed
Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response.
Authors: Authors: Cartner SC, Simecka JW, Lindsey JR, Cassell GH, Davis JK.
Infect Immun
View full abstract on Pubmed